Skip to content

Improving Insulin Therapy With Enhanced Care Management

Improving Insulin Therapy With Enhanced Care Management and Peer Support

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00320112
Enrollment
244
Registered
2006-05-03
Start date
2007-02-28
Completion date
2010-03-31
Last updated
2015-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Keywords

telemedicine, case management, insulin, self-care

Brief summary

VA diabetes patients often have difficulty managing their self-care and accessing clinic-based services; many also lack social support to help them meet the demands of their illness. Enhanced support is especially important when undertaking and sustaining new challenging self-care tasks, such as initiating or intensifying insulin treatment regimens. Although some VAs have implemented telephone nurse care management programs supported by automated calling services, many are reluctant to adopt these models due to nursing shortages.

Detailed description

Background: VA diabetes patients often have difficulty managing their self-care and accessing clinic-based services; many also lack social support to help them meet the demands of their illness. Enhanced support is especially important when undertaking and sustaining new challenging self-care tasks, such as initiating or intensifying insulin treatment regimens. Although some VAs have implemented telephone nurse care management programs supported by automated calling services, many are reluctant to adopt these models due to nursing shortages. Objectives: This randomized trial will evaluate an intervention using a low-cost interactive voice response (IVR) exchange system to promote peer-to-peer communication among diabetes patients initiating or increasing insulin therapy under medical guidance. The intervention is based on research demonstrating the positive impact of peer support on chronic disease outcomes and self-care behaviors, our own prior studies demonstrating the effectiveness of IVR-based self-management supports for VA diabetes patients, and a successful pilot study demonstrating VA diabetes patients' willingness to participate in IVR-facilitated peer support. The Specific Aims are: (1) To evaluate the effect of IVR-facilitated peer support on diabetes patients' glycemic control (including their A1c levels, insulin doses, hypo- and hyperglycemic symptoms) and use of VA care; (2) To assess the impact of IVR-facilitated peer support on patient-centered outcomes, including patients' satisfaction with care, perceived social support, diabetes-specific quality of life, and self-care behaviors; and (3) To identify patient characteristics associated with participation and use of IVR peer support, and mediators of the intervention's impact on patient outcomes. Methods: 324 diabetes patients with inadequate glycemic control who are candidates for insulin initiation or intensification will be recruited from 2 VA facilities (Ann Arbor, and Toledo). We will pair eligible patients based on age, gender, and whether they are initiating or increasing insulin. Pairs will be randomized to either: 1) usual care; or 2) usual care in conjunction with the IVR-based peer support program. After their orientation, intervention participants will be asked to communicate weekly with their partner using the IVR exchange. The IVR service is designed to allow patients to communicate without divulging their home phone number, experiencing toll charges, or being responsible for insuring that contacts occur without the assistance of reminder prompts. Intervention patients who have achieved adequate glycemic control at their 6-month follow up will be encouraged to select a new treatment goal. Patients will continue to participate in weekly IVR calls for 6 months. Research staff will monitor the process via the Internet, and outcomes will be measured at six months. The primary endpoint will be HbA1c levels at 6 and 12-months. Secondary endpoints include other physiological measures and patient-centered outcomes. The intervention is designed to interact with standard outpatient VA staffing models. We will develop detailed training materials that facilitate implementation in other facilities and work with clinical managers to facilitate roll-out if the intervention is found to be effective. Status: Recruitment of participants is complete as well as most preliminary data analyses. 12 month data is now being analyzed.

Interventions

BEHAVIORALReciprocal Diabetes Peer Support Program

participants are paired with another age-matched participation. Paired peer partners were encouraged to talk weekly using a telephone platform that recorded call frequency and duration and provided automated reminders promoting peer contact.

patients are not paired in the NCM arm attended a 1.5 hour session to receive education on care manager services and diabetes educational materials and be assigned to a nurse care manager with whom they were encouraged to follow-up regularly.

BEHAVIORALgroup outpatient counseling visits

Participants in the peer group were also offered three optional 1.5 hour patient-driven group sessions at month 1, 3, and 6

Sponsors

US Department of Veterans Affairs
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* type 2 diabetes * HbA1c \> 7% * age \> 21

Exclusion criteria

* substance abuse disorder * serious psychiatric illness * serious hearing loss * life expectancy \< 12 months

Design outcomes

Primary

MeasureTime frameDescription
Change in Glycemic Control (HbA1c)6 months (baseline to 6 months)The primary outcome was change between baseline and six-month Hemoglobin A1c (HbA1c), measured with a Bayer DCA 2000+ point-of-care analyzer.

Secondary

MeasureTime frameDescription
Change in Systolic Blood Pressure Measurechange in blood pressure at 6 monthssecondary outcome measure was change in blood pressure comparison of peer support group and nurse case management group from baseline to six months
Change in Diastolic Blood Pressure6 months from baselinechange in diastolic blood pressure was measured at 6 months
Number of Participants With Insulin Starts at 6 Months6 months (baseline to 6 months follow-up)the number of insulin starts at 6 months from baseline.

Countries

United States

Participant flow

Participants by arm

ArmCount
Receiprocal Peer Support
participants in the intervention arm are paired with a peer Peer-support telephone calls: peers are paired during the group visit and are encouraged to speak with their partner at least once a week for the 6 month duration of the study. group outpatient counseling visits: participants are given the option to attend 3 optional group visits with other participants and case managers. this gives them the opportunity to ask any diabetes related questions of nurses or other participants who have diabetes.
125
Nurse Case Management
participants were randomized to receive usual care with an initial educational session to review lab results and discuss any questions related to educational handouts
119
Total244

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyDeath21
Overall StudyLost to Follow-up34
Overall StudyWithdrawal by Subject30

Baseline characteristics

CharacteristicReceiprocal Peer SupportNurse Case ManagementTotal
Age, Continuous61.8 years
STANDARD_DEVIATION 6.1
62.3 years
STANDARD_DEVIATION 6.6
62.0 years
STANDARD_DEVIATION 6.3
Annual Income
greater than or equal to $31,000
46 participants41 participants87 participants
Annual Income
less than or equal to $30,000
78 participants71 participants149 participants
Annual Income
other or unknown
1 participants7 participants8 participants
Anti-hyperglycemic Medications
Insulin, + or - oral medication
70 participants66 participants136 participants
Anti-hyperglycemic Medications
Only oral diabetes medication
55 participants53 participants108 participants
Diastolic Blood Pressure77.1 mmHg
STANDARD_DEVIATION 11.5
75.8 mmHg
STANDARD_DEVIATION 10.7
76.5 mmHg
STANDARD_DEVIATION 11.1
Education
at least some college, technical\vocational school
91 participants83 participants174 participants
Education
Some High School, High School
34 participants35 participants69 participants
Education
unknown
0 participants1 participants1 participants
HbA1c8.02 percent HbA1c
STANDARD_DEVIATION 1.32
7.93 percent HbA1c
STANDARD_DEVIATION 1.4
7.98 percent HbA1c
STANDARD_DEVIATION 1.4
Race/Ethnicity, Customized
African American
11 participants11 participants22 participants
Race/Ethnicity, Customized
Hispanic
5 participants2 participants7 participants
Race/Ethnicity, Customized
Other
9 participants5 participants14 participants
Race/Ethnicity, Customized
unkwown
1 participants3 participants4 participants
Race/Ethnicity, Customized
White, non-Hispanic
99 participants98 participants197 participants
Self-Rated General Health Status - Fair or Poor Health59 participants64 participants123 participants
Sex: Female, Male
Female
0 Participants0 Participants0 Participants
Sex: Female, Male
Male
125 Participants119 Participants244 Participants
Social Support
Lives alone
29 participants22 participants51 participants
Social Support
Lives with a spouse
82 participants84 participants166 participants
Social Support
Other
14 participants13 participants27 participants
Systolic Blood Pressure140.3 mmHg
STANDARD_DEVIATION 18.6
136.4 mmHg
STANDARD_DEVIATION 16.9
138.4 mmHg
STANDARD_DEVIATION 17.9

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 1250 / 119
serious
Total, serious adverse events
2 / 1251 / 119

Outcome results

Primary

Change in Glycemic Control (HbA1c)

The primary outcome was change between baseline and six-month Hemoglobin A1c (HbA1c), measured with a Bayer DCA 2000+ point-of-care analyzer.

Time frame: 6 months (baseline to 6 months)

Population: Peer Support group: 117 of the 125 provided 6 month data and 113 provided physiologic measures. Nurse Case management participants: 114 of 119 provided 6 month data and 103 provided follow-up physiologic measures.

ArmMeasureGroupValue (MEAN)Dispersion
Reciprocal Peer Support GroupChange in Glycemic Control (HbA1c)Baseline percent A1c8.02 percent HbA1cStandard Deviation 1.32
Reciprocal Peer Support GroupChange in Glycemic Control (HbA1c)6 month percent A1c7.73 percent HbA1cStandard Deviation 1.32
Nurse Case Management GroupChange in Glycemic Control (HbA1c)Baseline percent A1c7.93 percent HbA1cStandard Deviation 1.4
Nurse Case Management GroupChange in Glycemic Control (HbA1c)6 month percent A1c8.22 percent HbA1cStandard Deviation 1.74
p-value: 0.004Regression, Linear
Secondary

Change in Diastolic Blood Pressure

change in diastolic blood pressure was measured at 6 months

Time frame: 6 months from baseline

Population: As noted earlier, for physiologic measures only 113 of the 125 peer support participants were able to provide 6 month follow-up data and 103 of 119 nurse management group provided 6 month follow-up data.

ArmMeasureGroupValue (MEAN)Dispersion
Reciprocal Peer Support GroupChange in Diastolic Blood Pressurebaseline diastolic blood pressure77.1 mmHgStandard Deviation 11.5
Reciprocal Peer Support GroupChange in Diastolic Blood Pressure6 month diastolic blood pressure76.8 mmHgStandard Deviation 11.9
Nurse Case Management GroupChange in Diastolic Blood Pressurebaseline diastolic blood pressure75.8 mmHgStandard Deviation 10.7
Nurse Case Management GroupChange in Diastolic Blood Pressure6 month diastolic blood pressure76.1 mmHgStandard Deviation 10.6
p-value: 0.1Regression, Linear
Secondary

Change in Systolic Blood Pressure Measure

secondary outcome measure was change in blood pressure comparison of peer support group and nurse case management group from baseline to six months

Time frame: change in blood pressure at 6 months

Population: comparison of blood pressure measure taken at baseline and then again at 6 months among the two groups. as noted, 113 peer support participants provided physiologic measures at 6 months and 103 of 119 from the nurse management group provided physiologic measures at 6 months.

ArmMeasureGroupValue (MEAN)Dispersion
Reciprocal Peer Support GroupChange in Systolic Blood Pressure Measurebaseline systolic blood pressure140.3 mmHgStandard Deviation 18.6
Reciprocal Peer Support GroupChange in Systolic Blood Pressure Measure6 month systolic blood pressure136.9 mmHgStandard Deviation 16.8
Nurse Case Management GroupChange in Systolic Blood Pressure Measurebaseline systolic blood pressure136.4 mmHgStandard Deviation 16.9
Nurse Case Management GroupChange in Systolic Blood Pressure Measure6 month systolic blood pressure135.0 mmHgStandard Deviation 17.7
p-value: 0.91Regression, Linear
Secondary

Number of Participants With Insulin Starts at 6 Months

the number of insulin starts at 6 months from baseline.

Time frame: 6 months (baseline to 6 months follow-up)

Population: medical charts were reviewed to obtain this information and all participant charts were reviewed

ArmMeasureValue (NUMBER)
Reciprocal Peer Support GroupNumber of Participants With Insulin Starts at 6 Months8 participants
Nurse Case Management GroupNumber of Participants With Insulin Starts at 6 Months1 participants
p-value: 0.02Regression, Linear

Source: ClinicalTrials.gov · Data processed: Mar 30, 2026